Obstructive sleep apnea and 12-month weight loss in adults with class 3 obesity attending a multidisciplinary weight management program
BMC Endocrine Disorders Nov 23, 2021
Kobuch S, Tsang F, Chimoriya R, et al. - Among adults with class 3 obesity, implementation of a multidisciplinary weight management program conferred significant weight loss at 12 months, irrespective of obstructive sleep apnea (OSA) diagnosis or continuous positive air pressure (CPAP) use.
In adults with class 3 obesity attending a multidisciplinary weight management program, the link between OSA and CPAP usage, and 12-month weight change, were assessed.
A total of 178 patients joined the program and 111 (62.4 %) completed 12 months in the program; OSA at baseline was present in 63.1 % (n=70), of whom 54.3 % (n=38) were receiving CPAP.
In all three groups (non-OSA group, OSA with CPAP, and OSA without CPAP), significant weight loss was evident at 12 months.
The percentage of body weight loss, or the proportion of patients who achieved ≥5 % body weight loss, did not differ statistically significantly across groups.
Glycosylated hemoglobin in type 2 diabetes mellitus patients decreased significantly from baseline to 12 months (7.8±1.7 % to 7.3±1.4 %), with no difference between groups.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries